米非司酮+宫瘤消胶囊治疗子宫肌瘤的效果  

The effect of mifepristone+Gongliuxiao capsules in the treatment of uterine fibroids

作　　者：黄鑫 Huang Xin(Department of Gynecology,Tonghua Central Hospital,Tonghua 134001,China)

机构地区：[1]通化市中心医院妇科,吉林通化134001

出　　处：《实用妇科内分泌电子杂志》2024年第13期50-52,共3页Electronic Journal of Practical Gynecological Endocrinology

摘　　要：目的 探讨米非司酮+宫瘤消胶囊治疗子宫肌瘤的效果。方法 选取本院收治的70例子宫肌瘤患者为研究对象,按1:1交替分配法分成两组,各35例。对照组采用米非司酮治疗,试验组采用米非司酮+宫瘤消胶囊治疗,比较两组的治疗效果、性激素水平、不良反应。结果 试验组治疗总有效率为94.29%,高于对照组的77.14%(P<0.05);试验组卵泡刺激素、孕酮、雌二醇、黄体生成素水平低于对照组(P<0.05);两组不良反应发生率比较差异无统计学意义(P>0.05)。结论 米非司酮+宫瘤消胶囊治疗子宫肌瘤,疗效显著,能改善性激素水平,且不增加不良反应。Objective To explore the effect of mifepristone+Gongyuxiao capsules in the treatment of uterine fibroids.Methods 70 patients with uterine fibroids admitted to our hospital were selected as the research subjects,and were divided into two groups using a 1:1 alternating allocation method,with 35 cases in each group.The control group was treated with mifepristone,while the experimental group was treated with mifepristone+Gongliuxiao capsules.The treatment effects,sex hormone levels,and adverse reactions of the two groups were compared.Results The total effective rate of the experimental group was 94.29%,higher than the control group's 77.14%(P<0.05);The levels of follicle stimulating hormone,progesterone,estradiol,and luteinizing hormone in the experimental group were lower than those in the control group(P<0.05);There was no statistically significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion Mifepristone combined with Gongyuxiao capsules has a significant therapeutic effect on uterine fibroids,improving hormone levels without incre asing adverse reactions.

关 键 词：子宫肌瘤 米非司酮 宫瘤消胶囊 临床疗效 性激素 不良反应 

分 类 号：R73[医药卫生—肿瘤]